Apolipoprotein E4-induced gene expression machinery

Apolipoprotein E4-induced gene expression machinery refers to the complex of proteins and regulatory processes through which the Apolipoprotein E4 (APOE4) isoform modulates gene expression in the nucleus. While traditionally recognized for its role in lipid transport, research has shown that APOE4 can translocate to the nucleus and act as a transcription factor or recruit epigenetic modifiers such as histone deacetylases HDAC4 and HDAC6 (Theendakara et al., 2016; Sen et al., 2015). This nuclear activity leads to the downregulation of neuroprotective genes like BDNF and NHE6, while upregulating pro-inflammatory and amyloidogenic pathways, thereby contributing to the pathogenesis of Alzheimer's disease (Prasad and Rao, 2018). Therapeutic strategies targeting this machinery aim to restore normal gene expression profiles by inhibiting APOE4's nuclear entry, disrupting its interaction with DNA binding sites—such as those recognized by Nuclear Respiratory Factor 1 (NRF1)—or modulating the activity of recruited enzymes like HDACs (Selonterra, 2024). Small molecule modulators are being developed by companies like Selonterra to address this novel target, and repurposed drugs like bumetanide have demonstrated the ability to reverse APOE4-driven transcriptomic signatures in preclinical models (Taubes et al., 2021). This approach represents a precision-medicine strategy specifically for APOE4 carriers, who face a significantly elevated risk of neurodegeneration.

Other names

APOE4-mediated transcriptional regulationAPOE4 nuclear translocation complexAPOE4-transcription factor complexAPOE4-NRF1 complexAPOE4-mediated gene regulatory network

Restoration of gene expression dysfunction, inhibition of APOE4 nuclear translocation, modulation of APOE4-DNA interactions (e.g., at NRF1 binding sites), and inhibition of recruited histone deacetylases such as HDAC4 and HDAC6.